David L Burgoyne

This inventor holds 15 USPTO granted patents, plus 1 CIPO patent and 1 EPO patent. Top assignees: Inflazyme Pharmaceuticals Ltd., The University of British Columbia, University of Alberta. Active years: 1996-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: David L Burgoyne. Retrieved from https://idiyas.com/inventor/david-l-burgoyne

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 15

% Patents Active = 53.3

CIPO Patents = 1 (Patent Applications = 3)

EPO Patents = 1 (Patent Applications = 2)

Average Co-Inventor Count = 5.5

ph-index = 6

Forward Citations = 116(Granted Patents)

Location History:

Vancouver, CA (1996 - 1997)
Delta, CA (2000 - 2024)

Company Filing History:

8 out of 11

Inflazyme Pharmaceuticals Ltd.

patents

5 out of 962

The University of British Columbia

patents

5 out of 455

University of Alberta

Naegis Pharmaceuticals Inc.

patents

6. 1 out of 834,513

Other

patents

where one patent can have more than one assignee

Years Active: 1996-2026

Loading Chart...

15 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12686668 - Leukotriene synthesis inhibitors (2026-07-21),

2. 11976052 - Leukotriene synthesis inhibitors (2024-05-07),

3. 7459479 - Benzylated PDE4 inhibitors (2008-12-02),

4. 7446129 - Benzylated PDE4 inhibitors (2008-11-04),

5. 7067682 - 6,7-Oxygenated steroids and uses related thereto (2006-06-27),

6. 6982329 - Process improvements in steroid chemistry (2006-01-03),

7. 6949533 - 6,7-Oxygenated steroids and uses related thereto (2005-09-27),

8. 6770658 - Substituted &ggr;-phenyl-&Dgr;-lactams and uses related thereto (2004-08-03),

9. 6706701 - 6, 7-oxygenated steroids and uses related thereto (2004-03-16),

10. 6696580 - Process for the production of 6,7-diols of steroidal compounds (2004-02-24),

11. 6555572 - Benzylated PDE4 inhibitors (2003-04-29),

12. 6458829 - Substituted &ggr;-phenyl-&Dgr;-lactones and analogs thereof and uses related thereto (2002-10-01),

13. 6046185 - 6,7-oxygenated steroids and uses related thereto (2000-04-04),

14. 5646138 - Contignasterol compounds and pharmaceutical compositions comprising the (1997-07-08),

15. 5506221 - Contignasterol, and related 3-alpha hydroxy-6-alpha hydroxy-7-beta (1996-04-09),

Title: The Innovative Journey of David L Burgoyne

Introduction: David L Burgoyne is a pioneering inventor based in Delta, California, known for his groundbreaking contributions to various fields.

Latest Patents: David L Burgoyne holds several patents in the areas of technology and engineering, showcasing his continuous commitment to innovation.

Career Highlights: With a career spanning over two decades, David L Burgoyne has established himself as a prominent figure in the world of inventions. His work has not only revolutionized industries but has also inspired aspiring inventors globally.

Collaborations: Throughout his career, David L Burgoyne has collaborated with leading companies, research institutions, and universities to further his innovative projects. These collaborations have led to the development of cutting-edge technologies that have had a significant impact on society.

Conclusion: David L Burgoyne's passion for innovation, coupled with his relentless drive to push boundaries, has solidified his position as a respected inventor in the field. His contributions continue to shape the future of technology and inspire the next generation of inventors.

Profile summary based on public USPTO records.